Accel Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,601
Closed -$119K 317
2023
Q1
$119K Buy
1,601
+77
+5% +$6.46K 0.05% 295
2022
Q4
$142K Buy
1,524
+27
+2% +$2.6K 0.07% 198
2022
Q3
$150K Sell
1,497
-150
-9% -$14.8K 0.08% 195
2022
Q2
$157K Sell
1,647
-198
-11% -$19.3K 0.09% 169
2022
Q1
$186K Sell
1,845
-98
-5% -$10.3K 0.1% 163
2021
Q4
$200K Buy
1,943
+1
+0.1% +$92 0.1% 167
2021
Q3
$165K Buy
1,942
+1
+0.1% +$84 0.11% 155
2021
Q2
$162K Buy
1,941
+333
+21% +$27.3K 0.11% 176
2021
Q1
$121K Buy
1,608
+616
+62% +$44.9K 0.1% 186
2020
Q4
$68K Buy
+992
New +$64.5K 0.06% 249

Other funds holding CVS

Accel Wealth Management's CVS Position: Q2 2023 in Review

Accel Wealth Management sold out of CVS Health (CVS) in Q2 2023, closing a stake of 1,601 shares — an estimated $119K sold.

Accel Wealth Management first reported a position in CVS in Q4 2020 and held it in 10 quarters. The position peaked at $200K in Q4 2021. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Accel Wealth Management reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Accel Wealth Management sold 1,601 CVS Health shares in Q2 2023, an estimated $119K.
  • Accel Wealth Management first reported a position in CVS Health in Q4 2020 and held it in 10 quarters.
  • Accel Wealth Management's CVS Health position peaked at $200K in Q4 2021.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Accel Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.